|
Quotes & Info
|
| ZLCS > SEC Filings for ZLCS > Form 8-K on 25-Oct-2012 | All Recent SEC Filings |
25-Oct-2012
Other Events, Financial Statements and Exhibits
On October 25, 2012, Zalicus Inc. ("Zalicus") issued a press release announcing that Sanofi provided an update on the development status of PrednisporinTM (FOV1101). The full text of Zalicus's press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
(d) Exhibits
Exhibit No. Description
99.1 Press release of Zalicus Inc. dated October 25, 2012.
|
|